1-3 of 3
Darja Karpova
Close
Sort by
Journal Articles

A simplified, G-CSF-free procedure allows for in vivo HSC gene therapy of sickle cell disease in a mouse model.

Chang Li, Anna Kate Anderson, Peter G Ruminski, Michael P Rettig, Darja Karpova, Hans-Peter Kiem, John F. DiPersio, André Lieber
Journal: Blood Advances
Blood Adv bloodadvances.2024012757.
https://doi.org/10.1182/bloodadvances.2024012757
Published: 2024
Includes: Supplemental data
Journal Articles

Targeting CXCR4, VLA-4, and CXCR2 for hematopoietic stem cell mobilization

Daniel Cancilla, Michael P. Rettig, Darja Karpova, Haresh Thakellapalli, Megh Singh, Marvin J. Meyers, Peter G. Ruminski, Stephanie Christ, Ezhilarasi Chendamarai, Feng Gao, Leah Gehrs, Julie K. Ritchey, Michael Prinsen, John F. DiPersio
Journal: Blood Advances
Blood Adv (2024) 8 (6): 1379–1383.
https://doi.org/10.1182/bloodadvances.2023011653
Published: 2024
Includes: Supplemental data
Journal Articles

Retained functional normal and preleukemic HSCs at diagnosis are associated with good prognosis in DNMT3A mut NPM1 mut AMLs

Elisa Donato, Nadia Correia, Carolin Andresen, Darja Karpova, Roberto Würth, Corinna Klein, Markus Sohn, Adriana Przybylla, Petra Zeisberger, Kathrin Rothfelder, Helmut Salih, Halvard Bonig, Sebastian Stasik, Christoph Röllig, Anna Dolnik, Lars Bullinger, Frank Buchholz, Christian Thiede, Daniel Hübschmann, Andreas Trumpp
Journal: Blood Advances
Blood Adv (2023) 7 (6): 1011–1018.
https://doi.org/10.1182/bloodadvances.2022008497
Published: 2023
Includes: Supplemental data